NCT01515839

Brief Summary

The investigators primary objective is to acquire preliminary data on one-hundred former NFL veterans with at least one full year of professional service using brain SPECT imaging in order to assess the degree to which NFL football puts players at risk for traumatic brain injury (TBI). TBI severity shall be gauged via visual inspection by a clinician trained in neuroanatomy, and also by a statistical comparison of subjects' brains to an in-house proprietary database comprised of the brains of healthy subjects. The investigators secondary objective is to acquire additional data on these players such that investigators may establish causative factors and risks associated with said TBI. The investigators tertiary objective is to acquire data on subjects using various mental health metrics in order to determine the effects of TBI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2010

Completed
1.3 years until next milestone

First Posted

Study publicly available on registry

January 24, 2012

Completed
Last Updated

January 24, 2012

Status Verified

January 1, 2012

Enrollment Period

1.1 years

First QC Date

October 1, 2010

Last Update Submit

January 23, 2012

Conditions

Keywords

SPECTImagingFootballTraumatic brain injuryRegional cerebral blood flow

Outcome Measures

Primary Outcomes (1)

  • A concentration SPECT scan will be given to assess the changes in regional cerebral blood flow to the brain in our study participants.

    For the concentration study the subject will start the Conner's Continuous Performance Task, a 15-minute computer-administered test of attention, subsequent to the accommodation period. Three minutes into task performance 20 milliCuries of Tc-99m-hexamethylpropylene amine oxime will be injected through the catheter with attention to minimal disruption of the subject's attention task. The subject will proceed to completion of the attention task. The concentration scans will then be compared to a healthy brain subject normative database.

    The SPECT scan is one day imaging exam. A follow up scan will be performed following a 2-12 month supplement intervention.

Secondary Outcomes (1)

  • Quantitative electroencephalography (QEEG) will be used to assess the damage to neural networks in our study participants.

    The QEEG testing is one day exam. A follow up test will be performed following a 2-12 month supplement intervention.

Study Arms (1)

Supplement intervention

EXPERIMENTAL

Dietary Supplement: Multivitamin, Omega 3 Supplement, Brain and Memory Formula

Dietary Supplement: Multivitamin Supplement intervention

Interventions

We recommend the following protocol: 1. 2 tablets of a high quality multivitamin BID 2. 2 capsules of omega 3 fish oil BID for a total of 3 grams daily 3. 3 capsules of a brain and memory formula BID which contains Acetyl-L-Carnitine (HCL) 1000 mg, Ginkgo Biloba Extract 120 mg, Alpha-Lipoic Acid (ALA) 300 mg, Huperzine A (Huperzia serrata)150 mcg, N-Acetyl-L-Cysteine (NAC) 600mg, Phosphatidyl Serine (soy) 100 mg, Vinpocetine 15mg 4. Weight loss

Also known as: Omega 3 Fatty Acid, Acetyl-L-Carnitine (HCL), Ginkgo Biloba Extract, Alpha-Lipoic Acid (ALA), Huperzine A (Huperzia serrata), N-Acetyl-L-Cysteine, Phosphatidyl Serine, Vinpocetine
Supplement intervention

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects must be at least 18 years of age
  • Each subject must have been on an active NFL roster for a minimum of one year

You may not qualify if:

  • Any subjects who could not cease taking psychoactive medications (recreational or otherwise) for an appropriate washout period prior to scanning were excluded from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amen Clinics, Inc.

Newport Beach, California, 92660, United States

Location

Related Publications (2)

  • Amen DG, Newberg A, Thatcher R, Jin Y, Wu J, Keator D, Willeumier K. Impact of playing American professional football on long-term brain function. J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):98-106. doi: 10.1176/jnp.23.1.jnp98.

  • Amen DG, Wu JC, Taylor D, Willeumier K. Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitation. J Psychoactive Drugs. 2011 Jan-Mar;43(1):1-5. doi: 10.1080/02791072.2011.566489.

MeSH Terms

Conditions

Brain Injuries, Traumatic

Interventions

Fatty Acids, Omega-3AcetylcarnitineGinkgo biloba extractThioctic Acidhuperzine AAcetylcysteinePhosphatidylserinesvinpocetine

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Dietary Fats, UnsaturatedDietary FatsFatsLipidsFatty Acids, UnsaturatedFatty AcidsFish OilsOilsCarnitineTrimethyl Ammonium CompoundsQuaternary Ammonium CompoundsAminesOrganic ChemicalsCarboxylic AcidsThiophenesSulfur CompoundsCoenzymesEnzymes and CoenzymesCysteineAmino Acids, SulfurAmino AcidsAmino Acids, Peptides, and ProteinsGlycerophospholipidsPhosphatidic AcidsGlycerophosphatesPhospholipidsMembrane Lipids

Study Officials

  • Daniel G Amen, MD

    Amen Clinics, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2010

First Posted

January 24, 2012

Study Start

May 1, 2009

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

January 24, 2012

Record last verified: 2012-01

Locations